Roche gets USFDA approval for molecular test to screen for malaria in blood donors Ruchika Sharma30 March 2024 2:30 PM ISTThe cobas Malaria test, a qualitative in vitro nucleic acid screening test, allows for direct detection of Plasmodium RNA and DNA in whole blood...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche cutting jobs in product development: Report Ruchika Sharma12 Feb 2024 2:06 PM ISTZurich: Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious...
Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types Ruchika Sharma20 Jan 2024 11:24 AM ISTBasel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...
Roche enters into agreement to acquire LumiraDx Point of Care technology combining multiple diagnostic modalities on single platform Ruchika Sharma30 Dec 2023 11:27 AM ISTBasel: Roche has announced the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx's innovative...
Roche Xolair gets USFDA priority review for children, adults with food allergies Ruchika Sharma20 Dec 2023 12:41 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted, under Priority Review, the company's supplemental...
Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 1:30 PM ISTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
CDSCO Panel approves Roche's PMS Study Report of Rituximab with Glucocorticoids in Wegener's Granulomatosis Dr. Divya Colin3 Dec 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved a post-marketing...
Roche launches Elecsys HBeAg quant for hepatitis B infection Ruchika Sharma28 Nov 2023 11:58 AM ISTIt can also simplify the experience for patients, as they only have to undergo one single test to indicate both the presence and quantity of HBeAg.
Roche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types Ruchika Sharma19 Nov 2023 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Roche unveils Elecsys Anti-HEV IgM, Elecsys Anti-HEV IgG immunoassays for hepatitis E virus infection detection Ruchika Sharma18 Nov 2023 10:00 AM ISTBasel: Roche has announced the launch of the Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV)...
Rznomics enters clinical trial collaboration with Roche to evaluate RZ-001 in combo with anti-PDL1 in liver cancer patients Ruchika Sharma15 Nov 2023 11:30 AM ISTSeongnam: Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, has...
